- Home
- TWIN vs TVGN Comparison
TWIN vs TVGN Comparison
Compare TWIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TWIN | TVGN |
|---|---|---|
| Founded | 1918 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 63.9M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | TWIN | TVGN |
|---|---|---|
| Price | $17.52 | $8.50 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.8K | 22.7K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $340,738,000.00 | N/A |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $10.28 | ★ N/A |
| Revenue Growth | ★ 15.45 | N/A |
| 52 Week Low | $6.90 | $0.14 |
| 52 Week High | $19.67 | $10.76 |
Technical Indicators
Market Signals| Indicator | TWIN | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 60.05 |
| Support Level | $14.38 | $0.47 |
| Resistance Level | $18.95 | $9.40 |
| Average True Range (ATR) | 1.27 | 0.88 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 56.66 | 62.65 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.